Production (Stage)
Celularity Inc.
CELU
$1.76
$0.010.57%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 138.11% | 225.94% | 182.02% | 109.81% | 26.68% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 138.11% | 225.94% | 182.02% | 109.81% | 26.68% |
| Cost of Revenue | -6.41% | 48.06% | 11.20% | -11.27% | -18.56% |
| Gross Profit | 480.77% | 887.40% | 20,190.63% | 1,171.63% | 499.70% |
| SG&A Expenses | 15.95% | -1.65% | -11.52% | -20.20% | -23.39% |
| Depreciation & Amortization | -20.06% | -11.99% | -3.88% | 0.23% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -6.53% | -21.43% | -35.32% | -44.02% | -40.30% |
| Operating Income | 49.59% | 59.00% | 62.74% | 61.45% | 48.42% |
| Income Before Tax | 70.51% | 80.68% | -36.36% | -1,281.78% | -1,481.80% |
| Income Tax Expenses | -- | -23.08% | 350.00% | -23.08% | -23.08% |
| Earnings from Continuing Operations | 70.51% | 80.68% | -36.38% | -1,283.03% | -1,483.14% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 70.51% | 80.68% | -36.38% | -1,283.03% | -1,483.14% |
| EBIT | 49.59% | 59.00% | 62.74% | 61.45% | 48.42% |
| EBITDA | 54.39% | 64.07% | 67.49% | 65.59% | 51.63% |
| EPS Basic | 76.58% | 84.65% | -20.33% | -733.61% | -1,992.95% |
| Normalized Basic EPS | 48.47% | 80.80% | 85.76% | 65.98% | 38.59% |
| EPS Diluted | 76.58% | 85.21% | -10.65% | -1,340.00% | -30,504.32% |
| Normalized Diluted EPS | 48.47% | 79.85% | 84.97% | 63.72% | 35.13% |
| Average Basic Shares Outstanding | 22.95% | 26.72% | 30.97% | 31.95% | 27.29% |
| Average Diluted Shares Outstanding | 22.95% | 19.60% | 21.65% | 19.91% | 15.20% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |